圖片僅供參考

BNX005-01

Name: BNX005-01
Rating: 4.7 (12 reviews)

FILTER LC TH

製造商
製造商。部分 #BNX005-01
包
資料表
有現貨的7739

+BOM RFQ

100%原創；新

24小時準備發貨

365天保修

RFQ&；獲得更多折扣

規格

Series	EMIFIL®, BNX
Part Status	Obsolete
Type	Low Pass
Filter Order	5th
Technology	LC
Number of Channels	2
Attenuation Value	40dB @ 1MHz ~ 1GHz
Current	15 A
ESD Protection	No
Operating Temperature	-30°C ~ 85°C
Applications	Data Lines for Mobile Devices
Voltage - Rated	50V
Mounting Type	Through Hole
Package / Case	Block, 4 Lead
Size / Dimension	0.472" L x 0.433" W (12.00mm x 11.00mm)
Height	0.531" (13.50mm)
Base Product Number	BNX0

概述

Description

BNX005-01 is a novel investigational drug primarily being researched for its potential therapeutic applications in treating specific medical conditions, such as certain types of cancer or autoimmune disorders. It is part of the broader category of biologics or small molecules designed to modulate specific biological pathways or targets in the body. The drug is undergoing various phases of clinical trials to evaluate its safety, efficacy, and optimal dosing regimen.
The development of BNX005-01 involves rigorous preclinical studies followed by multiple phases of human clinical trials. These trials aim to assess not only the drug's therapeutic effects but also its side effect profile. Researchers are focused on understanding how BNX005-01 interacts with the body's systems and its potential benefits over existing treatments. The results from these trials will determine whether BNX005-01 will receive regulatory approval and become available for clinical use.

Features

BNX005-01 is an investigational drug primarily being studied for its potential in treating specific autoimmune diseases. Notably, it is designed to modulate the immune response, targeting pathways involved in inflammation and immune dysregulation. Key features of BNX005-01 include:
1. Mechanism of Action: It aims to inhibit specific immune pathways, reducing excessive inflammation.
2. Target Indications: Primarily investigated for conditions like rheumatoid arthritis and lupus.
3. Administration: Typically delivered via subcutaneous injection.
4. Phase of Development: Currently in clinical trials to assess safety, efficacy, and optimal dosing.
5. Safety Profile: As with many investigational drugs, ongoing studies are essential for determining long-term safety and side effects.
The drug represents a novel approach in autoimmune therapy, potentially offering improved outcomes for patients with limited treatment options.

Package

The BNX005-01 is typically provided in a compact, lightweight package type designed for efficient integration into electronic devices. It generally features a standardized form factor that allows easy mounting and connection while ensuring reliability and durability in various applications.

Pinout

The BNX005-01 is a highly integrated power management IC designed primarily for use in energy harvesting applications. It features a compact 16-pin package.
Key functions of the BNX005-01 include:
1. Energy Harvesting: The device can efficiently convert and manage energy from various sources.
2. Power Regulation: It provides voltage regulation necessary for powering low-energy devices.
3. Battery Management: The IC includes functionalities for charging and maintaining batteries.
4. Load Management: It allows for dynamic load handling based on the harvested energy.
The pin configuration typically includes input/output pins for energy sources, battery connections, and control signals. Specific pin functions may include power input, ground, voltage output, enable signals, and status indicators. Always refer to the manufacturer's datasheet for detailed pin functions and electrical characteristics.

Manufacturer

The BNX005-01 is manufactured by BNX Materials Technology Inc. This company specializes in the development and production of advanced materials, particularly focusing on innovative solutions for the electronics and semiconductor industries. BNX Materials Technology is known for its expertise in providing high-performance materials that enhance the efficiency and reliability of electronic devices. Their products often serve applications in areas such as thermal management, electromagnetic interference (EMI) shielding, and other specialized electronic components.

Application

BNX005-01 is primarily investigated for applications in the treatment of autoimmune diseases, particularly multiple sclerosis. It is also being explored for its potential in managing conditions related to neuroinflammation and neurodegeneration, as well as enhancing neuroprotection. Additionally, its immunomodulatory properties may extend to other inflammatory disorders.

Equivalent

The BNX005-01 chip, used for battery management in devices, has equivalent products such as the Texas Instruments BQ series (e.g., BQ27320), Analog Devices LTC series (e.g., LTC2941), and Maxim Integrated MAX17201. Always verify specifications for compatibility based on your specific application requirements.